Invitae Corp (NVTAQ)
0.001
0.00 (0.00%)
USD |
OTCM |
May 01, 15:58
Invitae Cash from Financing (Quarterly): -3.381M for Sept. 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -3.381M |
| June 30, 2023 | 0.876M |
| March 31, 2023 | -135.77M |
| December 31, 2022 | 0.599M |
| September 30, 2022 | -1.691M |
| June 30, 2022 | 3.77M |
| March 31, 2022 | -0.92M |
| December 31, 2021 | 7.031M |
| September 30, 2021 | -0.735M |
| June 30, 2021 | 1.124B |
| March 31, 2021 | 436.09M |
| December 31, 2020 | 444.23M |
| September 30, 2020 | 6.415M |
| June 30, 2020 | 221.79M |
| March 31, 2020 | 0.551M |
| December 31, 2019 | 2.341M |
| September 30, 2019 | 273.85M |
| June 30, 2019 | 2.462M |
| March 31, 2019 | 186.12M |
| December 31, 2018 | 16.03M |
| Date | Value |
|---|---|
| September 30, 2018 | 64.10M |
| June 30, 2018 | 57.68M |
| March 31, 2018 | 19.34M |
| December 31, 2017 | 2.133M |
| September 30, 2017 | 50.37M |
| June 30, 2017 | 0.813M |
| March 31, 2017 | 27.55M |
| December 31, 2016 | 47.50M |
| September 30, 2016 | 1.554M |
| June 30, 2016 | 2.731M |
| March 31, 2016 | 1.92M |
| December 31, 2015 | 1.789M |
| September 30, 2015 | 4.541M |
| June 30, 2015 | -0.769M |
| March 31, 2015 | 106.88M |
| December 31, 2014 | 66.26M |
| September 30, 2014 | 47.13M |
| June 30, 2014 | -0.103M |
| March 31, 2014 | -0.166M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-135.77M
Minimum
Mar 2023
1.124B
Maximum
Jun 2021
132.28M
Average
2.402M
Median
Cash from Financing (Quarterly) Benchmarks
| Laboratory Corp of America Holdings | -11.70M |
| Delcath Systems Inc | 0.001M |
| Star Equity Holdings Inc | 0.987M |
| CytoSorbents Corp | 12.21M |
| Progyny Inc | -5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -66.90M |
| Cash from Investing (Quarterly) | 5.117M |
| Free Cash Flow | -247.82M |
| Free Cash Flow Per Share (Quarterly) | -0.2497 |
| Free Cash Flow to Equity (Quarterly) | 0.378M |
| Free Cash Flow to Firm (Quarterly) | -62.17M |
| Free Cash Flow Yield | -95.92K% |